SCHEDULE 13D/A: Astrana Health Repurchases Shares from Major Shareholder Allied Physicians, Ownership Structure Shifts
Amendment to Statement of Beneficial Ownership (Schedule 13D) and Stock Repurchase Agreement
Astrana Health, Inc. has repurchased 300,000 shares of its common stock from Allied Physicians of California for $10.55 million, while Allied Physicians also declared a dividend of nearly 700,000 Astrana shares to its own stockholders.
Summary
- Allied Physicians of California (APC) sold 300,000 shares of Astrana Health, Inc. (the "Issuer") Common Stock back to the Issuer on January 17, 2025.
- The repurchase price was $35.17 per share, totaling $10,551,000.
- As of the filing date, APC beneficially owns 6,832,698 shares of Astrana Common Stock, representing approximately 12.2% of the Issuer's outstanding shares.
- APC has sole voting power over 5,589,677 shares (approximately 9.99% of outstanding shares) and shared voting power over the remaining 1,243,021 shares, as per a pre-existing Voting and Registration Rights Agreement.
- On January 15, 2025, APC declared a dividend of 699,896 shares of Astrana Common Stock to its own stockholders, which have not yet been distributed.
- The percentage ownership calculation is based on 56,252,730 shares outstanding as of November 6, 2024, minus the 300,000 repurchased shares.
- The transaction was structured as a private sale, exempt from Securities Act registration requirements.
- Kenneth Sim, Chairman of APC and Executive Chairman of Astrana's Board, exercised options to purchase 28,046 shares of Common Stock at $18.65 per share on November 18, 2024.
Sentiment
Score: 6
Explanation: The sentiment is moderately positive. The share repurchase indicates management's confidence and can be accretive to EPS. While a major shareholder is reducing its stake, it's partly through a dividend distribution, and the overall transaction is a planned corporate action rather than a distressed sale. The waiver of non-public information is a standard legal clause in private transactions.
Positives
- The share repurchase by Astrana Health can be viewed as a positive signal of management's confidence in the company's valuation and an efficient use of capital.
- The repurchase reduces the total number of outstanding shares, which can potentially lead to an increase in earnings per share (EPS) for remaining shareholders.
- The transaction was conducted as a private sale, which typically minimizes market disruption compared to open-market repurchases.
Negatives
- Allied Physicians of California, a significant long-term shareholder, is reducing its direct beneficial ownership in Astrana Health through both the sale to the company and a declared dividend of shares to its own stockholders, which could be interpreted as a reduction in direct commitment.
- The Stock Repurchase Agreement includes a clause where APC acknowledges Astrana may possess material non-public information and waives any claims related to its non-disclosure, highlighting potential information asymmetry in the private transaction.
Risks
- The transaction's completion is subject to conditions, including the absence of any 'Material Adverse Effect' on Astrana's business, assets, liabilities, financial condition, property, or results of operations.
- The transaction could be prevented by a 'Governmental Prohibition,' such as a Law or Order enacted by a Governmental Authority.
- APC's waiver of claims regarding Astrana's non-disclosure of non-public information, while legally structured, points to the inherent risk of information asymmetry in private transactions.
Future Outlook
Allied Physicians of California (APC) states that it acquired the Common Stock for investment purposes and may in the future acquire additional shares or dispose of some or all of its beneficially owned shares through open-market or privately negotiated transactions. APC also reserves the right to engage in hedging or similar transactions. APC does not have any present plan or proposal that would result in other actions described in Item 4 of Schedule 13D, except as may be proposed by its officers or directors in their capacity as officers and/or directors of Astrana Health or by Astrana's Board of Directors with their participation.
Management Comments
- Thomas S. Lam, M.D., Chief Executive Officer and Chief Financial Officer of Allied Physicians of California, certified the information in the Schedule 13D.
- Brandon K. Sim, Chief Executive Officer and President of Astrana Health, Inc., signed the Stock Repurchase Agreement on behalf of Astrana.
Industry Context
This document primarily details a specific corporate transaction involving a share repurchase and a major shareholder's ownership adjustments. It does not provide broader insights into industry trends or the competitive landscape of the healthcare sector in which Astrana Health operates.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Clarification of Voting Rights | The document reiterates that Allied Physicians of California's voting power is limited to 9.99% of outstanding shares due to a Voting and Registration Rights Agreement dated September 11, 2019, with any excess votes cast by proxy to the Issuer's management. | 2019-09-11 | This pre-existing agreement ensures management retains significant control over voting matters despite Allied Physicians' substantial ownership. |
| Legal Counsel Conflict Waiver | Both Astrana Health and Allied Physicians of California explicitly agreed to and acknowledged that Tin Kin Lee and Tin Kin Lee Law Office represent Astrana only in connection with this transaction, despite also representing APC in other unrelated matters, and irrevocably waived any conflict of interest. | 2025-01-17 | This waiver addresses potential conflicts of interest, ensuring the legal validity of the transaction and protecting both parties from future claims related to legal representation. |
Related Party Transactions
- Astrana Health, Inc. repurchased 300,000 shares of its Common Stock from Allied Physicians of California, a significant beneficial owner and a related party.
- Kenneth Sim, who is the Chairman and a director and stockholder of Allied Physicians of California, and the Executive Chairman of Astrana Health's Board of Directors, exercised options to purchase 28,046 shares of Common Stock.
Stakeholder Impact
- **Shareholders**: The share repurchase reduces the total number of outstanding shares, which could potentially increase the earnings per share (EPS) for existing shareholders. Allied Physicians' stockholders will receive a dividend of Astrana shares.
- **Company (Astrana Health)**: The company utilized over $10.5 million in cash for the repurchase, reducing its cash reserves but also its share count. This action reflects a strategic decision regarding capital allocation.
- **Allied Physicians of California**: This entity is reducing its direct stake in Astrana Health through the sale and dividend, potentially reallocating capital or distributing value to its own shareholders.
Next Steps
- Allied Physicians of California is expected to distribute 699,896 shares of Astrana Health Common Stock to its own stockholders, as these shares have not yet been distributed as of the filing date.
- Allied Physicians of California may acquire additional shares or dispose of some or all of its beneficially owned shares in the future.
- Allied Physicians of California may engage in hedging or similar transactions with respect to Astrana Health shares.
Key Dates
| Date | Description |
|---|---|
| 2017-12-19 | Original Statement of Beneficial Ownership on Schedule 13D filed by Allied Physicians of California. |
| 2019-09-11 | Voting and Registration Rights Agreement entered into between Astrana Health, Inc. and Allied Physicians of California. |
| 2024-11-06 | Date as of which 56,252,730 shares of Common Stock were reported by the Issuer as outstanding in its Quarterly Report on Form 10-Q. |
| 2024-11-18 | Kenneth Sim exercised options to purchase 28,046 shares of Common Stock. |
| 2025-01-15 | Allied Physicians of California declared a dividend of 699,896 shares of Astrana Health Common Stock to its stockholders. |
| 2025-01-17 | Date of event requiring filing of this statement; Allied Physicians of California sold 300,000 shares of Common Stock to Astrana Health, Inc. pursuant to a stock repurchase agreement. |
| 2025-01-22 | Date of signature for the Schedule 13D Amendment No. 8. |
Recommendation
holdKeywords
Astrana Health, Allied Physicians of California, Share Repurchase, Schedule 13D, Beneficial Ownership, Stock Dividend, Corporate Governance, SEC Filing, Investment, Healthcare
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.